Biotechnology company FortuneRock is set to float on the National Equities Exchange and Quotations in China, giving Jinhua Pharmaceuticals an exit.
FortuneRock, a China-based biotechnology company backed by pharmaceutical firm Jinhua Pharmaceuticals, has filed for an initial public offering (IPO) on the National Equities Exchange and Quotations (NEEQ) in China.
The company has submitted a preliminary prospectus to China’s securities commission, though the document is not yet available on the commission’s English language website.
FortuneRock is developing a range of treatments for life-threatening and debilitating diseases. It secured $24m in pre-IPO funding from Jinhua Pharmaceuticals and two undisclosed private investors…
